133 related articles for article (PubMed ID: 37989104)
1. FoxP3-Positive Cells and Their Contacts with Mast Cells Are Highly Increased in Basal Cell Carcinoma.
Kaukinen AP; Harvima RJ; Harvima IT
Int Arch Allergy Immunol; 2024; 185(2):167-169. PubMed ID: 37989104
[TBL] [Abstract][Full Text] [Related]
2. The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma.
Diaconu NC; Kaminska R; Naukkarinen A; Harvima RJ; Harvima IT
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):908-15. PubMed ID: 17658999
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactivity to CYP24A1, but not vitamin D receptor, is increased in mast cells of keratinocyte skin cancers.
Kaukinen A; Siiskonen H; Pelkonen J; Harvima IT
Eur J Dermatol; 2017 Dec; 27(6):590-598. PubMed ID: 29165303
[TBL] [Abstract][Full Text] [Related]
4. Mast cells express CYP27A1 and CYP27B1 in epithelial skin cancers and psoriasis.
Kaukinen A; Pelkonen J; Harvima IT
Eur J Dermatol; 2015; 25(6):548-55. PubMed ID: 26463745
[TBL] [Abstract][Full Text] [Related]
5. CD40 Ligand Is Increased in Mast Cells in Psoriasis and Actinic Keratosis but Less So in Epithelial Skin Carcinomas.
Haimakainen S; Kaukinen AP; Suttle MM; Pelkonen J; Harvima IT
Cancer Invest; 2017 Mar; 35(3):143-151. PubMed ID: 28267402
[TBL] [Abstract][Full Text] [Related]
6. Increased mast cell expression of PAR-2 in skin inflammatory diseases and release of IL-8 upon PAR-2 activation.
Carvalho RF; Nilsson G; Harvima IT
Exp Dermatol; 2010 Feb; 19(2):117-22. PubMed ID: 19889021
[TBL] [Abstract][Full Text] [Related]
7. Expression of mast cell tryptase and immunoglobulin E is increased in cutaneous photodamage: implications for carcinogenesis.
Korhonen J; Siiskonen H; Haimakainen S; Harvima RJ; Harvima IT
J Dermatolog Treat; 2024 Dec; 35(1):2307488. PubMed ID: 38291602
[No Abstract] [Full Text] [Related]
8. Mast cell tryptase and chymase are potential regulators of neurogenic inflammation in psoriatic skin.
Naukkarinen A; Harvima IT; Aalto ML; Horsmanheimo M
Int J Dermatol; 1994 May; 33(5):361-6. PubMed ID: 8039976
[TBL] [Abstract][Full Text] [Related]
9. Increase in CD30 ligand/CD153 and TNF-alpha expressing mast cells in basal cell carcinoma.
Diaconu NC; Kaminska R; Naukkarinen A; Harvima RJ; Nilsson G; Harvima IT
Cancer Immunol Immunother; 2007 Sep; 56(9):1407-15. PubMed ID: 17268792
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of tryptase- and chymase-containing mast cells in cutaneous lichen planus.
Harvima IT; Naukkarinen A; Harvima RJ; Aalto ML; Neittaanmäki H; Horsmanheimo M
Acta Derm Venereol; 1991; 71(5):394-8. PubMed ID: 1721758
[TBL] [Abstract][Full Text] [Related]
11. Mast cells in basal cell carcinoma express VEGF, IL-8 and RANTES.
Aoki M; Pawankar R; Niimi Y; Kawana S
Int Arch Allergy Immunol; 2003 Mar; 130(3):216-23. PubMed ID: 12660426
[TBL] [Abstract][Full Text] [Related]
12. Increased dermal mast cell prevalence and susceptibility to development of basal cell carcinoma in humans.
Grimbaldeston MA; Skov L; Finlay-Jones JJ; Hart PH
Methods; 2002 Sep; 28(1):90-6. PubMed ID: 12231192
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive Environment in Basal Cell Carcinoma: The Role of Regulatory T Cells.
Omland SH; Nielsen PS; Gjerdrum LM; Gniadecki R
Acta Derm Venereol; 2016 Nov; 96(7):917-921. PubMed ID: 27117439
[TBL] [Abstract][Full Text] [Related]
14. Demonstration of tryptase in bovine cutaneous and tumor mast cells.
Welle MM; Proske SM; Harvima IT; Schechter NM
J Histochem Cytochem; 1995 Nov; 43(11):1139-44. PubMed ID: 7560896
[TBL] [Abstract][Full Text] [Related]
15. Local immune response in cutaneous basal cell carcinoma.
Omland SH
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975891
[TBL] [Abstract][Full Text] [Related]
16. The significance of mast cells associated with basal cell carcinoma.
Erkiliç S; Erbağci Z
J Dermatol; 2001 Jun; 28(6):312-5. PubMed ID: 11476109
[TBL] [Abstract][Full Text] [Related]
17. Can smoking and/or occupational UV exposure have any role in the development of the morpheaform basal cell carcinoma? A critical role for peritumoral mast cells.
Erbagci Z; Erkiliç S
Int J Dermatol; 2002 May; 41(5):275-8. PubMed ID: 12100702
[TBL] [Abstract][Full Text] [Related]
18. Mast cell tryptase and chymase in the progress of cutaneous vasculitis.
Lipitsä T; Naukkarinen A; Harvima IT
Arch Dermatol Res; 2015 Dec; 307(10):917-24. PubMed ID: 26498154
[TBL] [Abstract][Full Text] [Related]
19. Computer analysis of normal and basal cell carcinoma mast cells.
Janowski P; Strzelecki M; Brzezińska-Błaszczyk E; Zalewska A
Med Sci Monit; 2001; 7(2):260-5. PubMed ID: 11257733
[TBL] [Abstract][Full Text] [Related]
20. Silibinin inhibits ultraviolet B radiation-induced mast cells recruitment and bone morphogenetic protein 2 expression in the skin at early stages in Ptch(+/-) mouse model of basal cell carcinoma.
Rigby C; Deep G; Jain A; Orlicky DJ; Agarwal C; Agarwal R
Mol Carcinog; 2019 Jul; 58(7):1260-1271. PubMed ID: 30912211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
